Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Pulmatrix Receives Study May Proceed Letter From FDA For Phase 2 Study To Evaluate PUR3100
posted:
Tue, 09/19/2023 - 09:21 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Arcutis' INTEGUMENT-PED Phase 3 Study Of Roflumilast Cream 0.05% Meets Primary Goal
posted:
Tue, 09/19/2023 - 08:26 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Volvo Cars To Completely Phase Out Diesels By Early 2024
posted:
Tue, 09/19/2023 - 08:21 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Astellas Pharma Announces Positive Results From Phase 3 Trial Of Izervay In Geographic Atrophy
posted:
Mon, 09/18/2023 - 22:03 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Allergan Aesthetics: Second Phase 3 Study With OnabotulinumtoxinA Meets Endpoints
posted:
Mon, 09/18/2023 - 09:36 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Aclaris Reports Positive Phase 1 MAD Trial Results Of ATI-2138; To Progress To Phase 2a Trials
posted:
Mon, 09/18/2023 - 08:02 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Global climate protests demand world leaders phase out fossil fuels
posted:
Thu, 09/14/2023 - 20:01 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
posted:
Wed, 09/13/2023 - 08:19 EDT
by:
CNBC Business
#channels::
#All
,
#News
,
#Business
,
#CNBCBusiness
,
#CNBC
,
#Stocks
,
#Markets
AZN : Phase III Trial Of FASENRA In Eosinophilic Granulomatosis With Polyangiitis Meets Main Goal
posted:
Mon, 09/11/2023 - 22:56 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Crinetics : Phase 3 Study Of Paltusotine In Acromegaly Meets Primary And Secondary Endpoints
posted:
Sun, 09/10/2023 - 21:36 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Amgen Reports Positive Data From Phase 1 Study Of Lumakras Combination In Non-small Cell Lung Cancer
posted:
Sun, 09/10/2023 - 11:16 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Valneva Reports Positive Pediatric & Adolescent Phase 2 Booster Results For Lyme Disease Vaccine
posted:
Thu, 09/07/2023 - 01:34 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Tonix Pharma Reports Topline Results From Phase 2 PREVAIL Proof-of-Concept Study Of TNX-102 SL
posted:
Tue, 09/05/2023 - 07:48 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Genmab : Phase 3 Trial Of TIVDAK In Recurrent Or Metastatic Cervical Cancer Meets Primary Endpoint
posted:
Mon, 09/04/2023 - 21:25 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Genmab, Seagen say phase three of innovaTV 301 trial met primary endpoint
posted:
Mon, 09/04/2023 - 15:29 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Pagination
Previous page
‹‹
Page 10
Next page
››